Recipient of federal assistance · NEW YORK, NY

GILGAMESH PHARMACEUTICALS INC

GILGAMESH PHARMACEUTICALS INC received -$1.9M in federal grants and other assistance in FY2026, on 3 actions, −169% vs FY2025. It has no federal contracts in the loaded years. Since FY2024: $3.6M.

Assistance · FY2026
-$1.9M
New awards
0
Actions
3
Since FY2024
$3.6M
UEI
Q6NKZ88FJMT5
Location
NEW YORK, NY
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 2.7MFY2024
  2. 2.7MFY2025
  3. -1.9MFY2026

By type

  1. Grants-$1.9M0.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.279 · Drug Use and Addiction Research Programs-$1.9M0.0%

Largest awards

  1. DEVELOPMENT OF A SAFER AND MORE EFFECTIVE IBOGAINE ANALOG FOR THE TREATMENT OF OPIOID USE DISORDER - SUMMARY OPIOID USE DISORDER (OUD)…$5.4M
    93.279 · Drug Use and Addiction Research Programs· National Institutes of Health· Cooperative agreement· Feb 26, 2024 – Jul 2, 2026· UG3DA060053

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2024–FY2026.